DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Moprolol
Moprolol
1-(4-Amino-Cyclohexyl)
Antiglaucoma Compositions Containing Combinations of Alpha-2 Agonists and Beta-Blockers
The Organic Chemistry of Drug Synthesis
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Customs Tariff - Schedule
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
PAPER SPRAY MASS SPECTROMETRY for RAPID DRUG SCREENING by Rachel Jett
Stembook 2018.Pdf
SUPPLEMENTARY MATERIAL 1: Search Strategy
2021 Equine Prohibited Substances List
Pharmacotherapy for Mild Hypertension (Review) – the Cochrane Collaboration
(12) Patent Application Publication (10) Pub. No.: US 2004/0058896 A1 Dietrich Et Al
Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists
Council of Europe Committee of Ministers (Partial
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Customs Tariff - Schedule
Top View
2019 Equine Prohibited Substances List
Statistical Analysis Plan: 20140254 Date: 07 January 2017 Page 24
Transdermal Device Containing
Drug-Resin Complexes Stabilized by Chelating Agents
Customs Tariff - Schedule Xxi - 1
Solutions Your Api Intermediates
WO 2012/088441 Al 28 June 2012 (28.06.2012) P O P C T
Progress in the Enantioseparation of -Blockers by Chromatographic Methods
2019 Banned Substances List.Pdf
Harmonized Tariff Schedule of the United States (2006) (Rev
Chromtech Chiral
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Asymmetric Synthesis Towards Bioactive
Pharmacotherapy for Hypertension in Adults Aged 18 to 59 Years (Review)
Adrenergic Blockers in Regard to Their Stereochemistry
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Biocatalytic Approaches to Optically Active Β-Blockers
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
(19) United States (12) Patent Application Publication (10) Pub
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
Resolution Ap (2000) 1
Substance Activity
Ep 1472225 B1
(12) Patent Application Publication (10) Pub. No.: US 2015/0309021 A1 Birnbaum Et Al
Name:- Dr. Rohitkumar Gulabrao Gore Address(Optional):- Personal
Validation of Rapid UPLC/MS/MS Qualitative Screening Method for Detection of Β-Blockers in Urine Samples